Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Siegel, 2021, Cancer Statistics, CA A Cancer J Clin, 71, 2021
Kelly, 2018, Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States, European urology focus, 4, 121, 10.1016/j.euf.2017.10.014
Lowrance Wt, 2021, Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline, J Urol
Mohler, 2019, Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Cancer Netw, 17, 479, 10.6004/jnccn.2019.0023
Cornford, 2021, EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer, Eur Urol, 79, 263, 10.1016/j.eururo.2020.09.046
Wang, 2018, The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis, Biosci Rep, 38
Ghadjar, 2015, The oncologic role of local treatment in primary metastatic prostate cancer, World J Urol, 33, 755, 10.1007/s00345-014-1347-9
Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012
Preisser, 2021, Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer, Prostate Int, 9, 113, 10.1016/j.prnil.2020.12.003
Yuh, 2019, Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer, Prostate Int, 7, 102, 10.1016/j.prnil.2018.10.002
Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29
Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 550, 10.1186/s13059-014-0550-8
Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102
O’Shaughnessy, 2017, A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer, Urology, 102, 164, 10.1016/j.urology.2016.10.044
Maolake, 2018, Tumor necrosis factor-alpha induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation, Cancer Sci, 109, 1524, 10.1111/cas.13586
Michalaki, 2004, Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer, Br J Cancer, 90, 2312, 10.1038/sj.bjc.6601814
Ranasinghe, 2020, The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer, BJU Int, 125, 792, 10.1111/bju.15055
Buyyounouski, 2017, Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual, CA A Cancer J Clin, 67, 245, 10.3322/caac.21391
Parker, 2018, Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial, Lancet, 392, 2353, 10.1016/S0140-6736(18)32486-3